Case Western Reserve Bioinformatics Expert Part of International “A” Team that Debuts Brain Cancer Atlas Experts and automated machine-learning techniques help glioblastoma research and treatment efforts June 4, 2018 VIEW…
PHOENIX, Ariz. — May 24, 2018 — In a first-of-its-kind clinical trial, a drug called AZD1775 was shown to penetrate deadly glioblastoma brain cancer cells, according to a study conducted at…
PHOENIX, Ariz. — May 9, 2018 — Imagine how much patients could benefit if you could discover the presence of cancer, and even how that cancer develops over time, with a…
PHOENIX, Ariz., and SEATTLE, Wash. — May 11, 2018 — This year, an estimated 13,000 Americans will be diagnosed with glioblastoma, which is the most deadly and aggressive form of brain…
The detection and analysis of rare blood biomarkers is necessary for early diagnosis of cancer and to facilitate the development of tailored therapies. Nature Biomedical Engineering July 16, 2018 VIEW…
Glioblastoma is a rapidly progressing disease with poor outcome, with a median overall survival (OS) of less than 15 months for patients with newly diagnosed glioblastoma. Though glioblastoma is a…
Use of arsenic trioxide could extend survival of some glioblastoma patients by three to four times historic median PHOENIX, Ariz. - Oct. 17, 2017 - From Sherlock Holmes to Agatha…
Team develops new tool, LumosVar, for discerning genetic variants; more genomic sequencing needed for clinical application to cancer patients PHOENIX and LOS ANGELES — Oct. 26, 2017 — Precision Medicine…
Encouraging early results following timely treatment guided by comprehensive genomic sequencing PHOENIX, Ariz. - Oct. 25, 2017 - Several patients with recurring glioblastoma, a deadly brain cancer, survived for more…
Dr. Waldemar Priebe is a medicinal chemist with an interest in brain tumors, and a drug he discovered and developed is on its way to a clinical trial at MD…